From charity funding to lab work, we explore the impact of both and how AMRC Open Research publishing platform contributes to dementia research. Read the Q&A with Rosa Sancho, Alzheimer’s Research UK, and Emily Kirkham, Cardiff University.
In this blog post Michael Markie, Publishing Director at F1000 Research, outlines the upcoming adjustments to the pricing structure on AMRC Open Research, Dr. Jocelyn LeBlanc, Research, Data and Impact Manager at the AMRC discusses the importance of price and service transparency of the platform.
Dr. Grant Mair, clinical academic neuroradiologist, discusses his research assessing Artificial Intelligence software to help global healthcare providers make informed decisions about which software to use in assessing patients with stroke.
Dr Rebecca Charlton and Dr Catherine Crompton discuss their Open Letter about social prescribing, where they examine the factors that should be considered when offering it to autistic adults and what can be done to help optimise the outcomes.
In this Q&A, Ms Bogna Drozdowska, PhD student, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Dr Terry Quinn joint Chief Scientist Officer and Stroke Association Senior Clinical Lecturer and Honorary Consultant Physician, Institute of Cardiovascular and Medical Sciences, University of Glasgow and Bernadett Tildy, Research Awards Officer, The Stroke Association discuss how AMRC Open Research will help maximise the visibility of Stroke Association-funded research.
Kate Flemming, Senior Lecturer in the Department of Health Sciences at the University of York and Sabine Best, Head of Research at Marie Curie, give their perspectives – as a researcher and charity worker respectively – on AMRC Open Research.
In this Q&A Chris Macdonald, Head of Research at Pancreatic Cancer UK and Geri Keane, Senior Clinical Fellow in Hepatology at Kings College Hospital and Honorary Research Fellow at UCL, discuss their thoughts on the application and future of AMRC Open Research.
Kelly Hares is a post-doc working for the University of Bristol at the MS and Stem Cell Group within Translational Health Sciences and the Institute of Clinical Neuroscience. Her research on KIFs in this particular study was funded by the charity: BRACE.
In this blog Philip Dooner, Associate Publisher at F1000 Platforms and Dr. Jocelyn LeBlanc, Impact Analyst at AMRC discuss the motivations behind establishing AMRC Open Research and their hopes for the future of this publishing platform.